173 related articles for article (PubMed ID: 14522850)
1. Trafficking, turnover and membrane topology of PrP.
Harris DA
Br Med Bull; 2003; 66():71-85. PubMed ID: 14522850
[TBL] [Abstract][Full Text] [Related]
2. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.
Nunziante M; Ackermann K; Dietrich K; Wolf H; Gädtke L; Gilch S; Vorberg I; Groschup M; Schätzl HM
J Biol Chem; 2011 Sep; 286(39):33942-53. PubMed ID: 21835918
[TBL] [Abstract][Full Text] [Related]
4. Physiological role of the cellular prion protein.
Zomosa-Signoret V; Arnaud JD; Fontes P; Alvarez-Martinez MT; Liautard JP
Vet Res; 2008; 39(4):9. PubMed ID: 18073096
[TBL] [Abstract][Full Text] [Related]
5. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
6. Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP
Hiller H; Yang C; Beachy DE; Kusmartseva I; Candelario-Jalil E; Posgai AL; Nick HS; Schatz D; Atkinson MA; Wasserfall CH
Diabetologia; 2021 Oct; 64(10):2279-2291. PubMed ID: 34274990
[TBL] [Abstract][Full Text] [Related]
7. Cellular prion protein is implicated in the regulation of local Ca2+ movements in cerebellar granule neurons.
Lazzari C; Peggion C; Stella R; Massimino ML; Lim D; Bertoli A; Sorgato MC
J Neurochem; 2011 Mar; 116(5):881-90. PubMed ID: 21214552
[TBL] [Abstract][Full Text] [Related]
8. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
[TBL] [Abstract][Full Text] [Related]
9. Prions disturb post-Golgi trafficking of membrane proteins.
Uchiyama K; Muramatsu N; Yano M; Usui T; Miyata H; Sakaguchi S
Nat Commun; 2013; 4():1846. PubMed ID: 23673631
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells.
Béranger F; Mangé A; Goud B; Lehmann S
J Biol Chem; 2002 Oct; 277(41):38972-7. PubMed ID: 12163492
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic prion protein in neurons.
Mironov A; Latawiec D; Wille H; Bouzamondo-Bernstein E; Legname G; Williamson RA; Burton D; DeArmond SJ; Prusiner SB; Peters PJ
J Neurosci; 2003 Aug; 23(18):7183-93. PubMed ID: 12904479
[TBL] [Abstract][Full Text] [Related]
12. Microdeletions within the hydrophobic core region of cellular prion protein alter its topology and metabolism.
Lutz J; Brabeck C; Niemann HH; Kloz U; Korth C; Lingappa VR; Bürkle A
Biochem Biophys Res Commun; 2010 Mar; 393(3):439-44. PubMed ID: 20138835
[TBL] [Abstract][Full Text] [Related]
13. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
14. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis.
Sunyach C; Checler F
J Neurochem; 2005 Mar; 92(6):1399-407. PubMed ID: 15748158
[TBL] [Abstract][Full Text] [Related]
15. Cell biological studies of the prion protein.
Harris DA
Curr Issues Mol Biol; 1999; 1(1-2):65-75. PubMed ID: 11475702
[TBL] [Abstract][Full Text] [Related]
16. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein.
Magalhães AC; Silva JA; Lee KS; Martins VR; Prado VF; Ferguson SS; Gomez MV; Brentani RR; Prado MA
J Biol Chem; 2002 Sep; 277(36):33311-8. PubMed ID: 12070160
[TBL] [Abstract][Full Text] [Related]
17. A New Take on Prion Protein Dynamics in Cellular Trafficking.
Alves RN; Iglesia RP; Prado MB; Melo Escobar MI; Boccacino JM; Fernandes CFL; Coelho BP; Fortes AC; Lopes MH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092231
[TBL] [Abstract][Full Text] [Related]
18. The highways and byways of prion protein trafficking.
Campana V; Sarnataro D; Zurzolo C
Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
[TBL] [Abstract][Full Text] [Related]
19. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
20. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
